URSAPHARM Arzneimittel y CEBINA anuncian una colaboración para readaptar el antihistamínico azelastine para combatir la COVID-19With the assistance of the design and style information, the audio content material on the films plus the interactive installations were being outlined to be able to not have an impact on one another.Pilot and Electriq I